Orthofix Medical (OFIX) Competitors

SI-BONE (NASDAQ:SIBN) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, community ranking, risk, analyst recommendations and valuation.

Does the media favor SIBN or OFIX?

In the previous week, SI-BONE and SI-BONE both had 2 articles in the media. Orthofix Medical's average media sentiment score of 0.93 beat SI-BONE's score of 0.31 indicating that SI-BONE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SI-BONE	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orthofix Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in SIBN or OFIX?

98.1% of SI-BONE shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 5.4% of SI-BONE shares are owned by company insiders. Comparatively, 4.7% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community favor SIBN or OFIX?

Orthofix Medical received 251 more outperform votes than SI-BONE when rated by MarketBeat users. However, 67.23% of users gave SI-BONE an outperform vote while only 61.80% of users gave Orthofix Medical an outperform vote.

Company	Underperform	Outperform
SI-BONE	Outperform Votes 160 67.23%	Underperform Votes 78 32.77%
Orthofix Medical	Outperform Votes 411 61.80%	Underperform Votes 254 38.20%

Which has better earnings and valuation, SIBN or OFIX?

SI-BONE has higher earnings, but lower revenue than Orthofix Medical. SI-BONE is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SI-BONE	$138.89M	4.17	-$43.34M	-$1.09	-12.89
Orthofix Medical	$746.64M	0.69	-$151.40M	-$3.38	-4.06

Do analysts rate SIBN or OFIX?

SI-BONE presently has a consensus target price of $27.29, indicating a potential upside of 94.20%. Orthofix Medical has a consensus target price of $18.00, indicating a potential upside of 31.10%. Given Orthofix Medical's stronger consensus rating and higher possible upside, analysts plainly believe SI-BONE is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Orthofix Medical	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Which has more risk and volatility, SIBN or OFIX?

SI-BONE has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

Is SIBN or OFIX more profitable?

Orthofix Medical has a net margin of -16.64% compared to Orthofix Medical's net margin of -29.93%. SI-BONE's return on equity of -14.24% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SI-BONE	-29.93%	-25.14%	-18.77%
Orthofix Medical	-16.64%	-14.24%	-9.49%

Summary

SI-BONE beats Orthofix Medical on 11 of the 17 factors compared between the two stocks.